Bill Nailon is a Clinical Scientist and Professor in the Department of Oncology Physics at the Edinburgh Cancer Centre where he is project lead for the Radiotherapy Physics, Radiomics and Cancer Informatics Group. He is also a visiting member of staff at the University of Edinburgh, College of Engineering, Institute for Digital Communications (IDCOM). More information and publications are available at Edinburgh Research Explorer.
He is involved in a number of projects aimed at improving radiotherapy, particularly in developing adaptive or personalised approaches using multi-disciplinary techniques, which are applicable to different tumour sites.
He is Principal Investigator on the CSO Scotland funded IMAGE-INE project, Analysing IMAGE guIdance scaNs to prEdict late toxicity after radiotherapy in head and neck cancer patients. This project brings together the Beatson West of Scotland Cancer Centre, Edinburgh Cancer Centre and the University of Cambridge to develop new imaging biomarkers for predicting xerostomia in head and neck cancer patients.
Duncan McLaren is a Consultant Clinical Oncologist and Professor in the Department of Clinical Oncology at the Edinburgh Cancer Centre. He specialises in genito-urinary oncology with a particular interest in prostate brachytherapy (seeds) and dose escalated hypo-fractionated radiotherapy. He is involved in a number of national and international clinical trials and has well-established links with academic colleagues within the NHS, and across a diverse range of university departments in the UK, Europe and the US.
In conjunction with colleagues from Glasgow and Aberdeen plus Scottish Government funding, he helped establish the current template for the Scottish Cancer Trials Network of multi-disciplinary, tumour specific clinical trials in 2002.
He has also contributed significantly by writing patient information booklets on the non-surgical treatment of prostate cancer on behalf of the charity Prostate Scotland, mentored and supported local prostate cancer support groups and invited GP education days.
More information and publications at Edinburgh Research Explorer.
Dr David Noble is a Consultant Clinical Oncologist at the Edinburgh Cancer Centre. Dr Noble recently completed a Clinical Research Training Fellowship with the Cambridge Cancer Centre, funded by CRUK, to obtain a PhD in adaptive radiotherapy for head and neck cancer .
He has a long-standing interest in machine learning in radiotherapy and is a Co-investigator on CSO Scotland funded grant on using machine learning to predict response/adaptation in head and neck cancer.
More information and publications are available Research Gate.
Dr Iain Phillips is a Consultant Clinical Oncologist at the Edinburgh Cancer Centre, Western General Hospital. His main research interest is in technical radiotherapy, advanced image analysis and weight loss in lung cancer. He is involved in a number of studies aimed at improving cancer treatment through the identification of biomarkers of response. He has recently been appointed an NRS Career Research Fellow and is an Honorary Senior Lecturer at the University of Surrey.
He completed an MD at the University of Surrey in 2017 on the extraction of greater data from standard CT imaging in non-Small cell lung cancer and has a long-standing interest in image analysis in radiotherapy.
More information and a list of publications are available at Research Gate.
Dr Thomas Berger completed a PhD at Aarhus University Hospital in Denmark on optimising external-beam radiotherapy treatment of cervix cancer patients treated by image-guided radiotherapy, Intensity-modulated radiotherapy, and proton therapy. He is currently a Research Fellow on a big-data analytics project where the focus is on identifying biomarkers, found by image analysis, that indicate when it is appropriate to adapt treatment in head and neck cancer patients. The project has access to daily images from over 300 patients for whom there is also complete longitudinal radiotherapy follow-up data available.
Linda Carruthers is Head of the Department of Oncology Physics at the Edinburgh Cancer Centre. She is a Consultant Clinical Scientist with specialist expertise in radiotherapy planning and intracranial stereotactic radiosurgery. She is a member of the Management Team at the Edinburgh Cancer with strategic responsibility for all radiotherapy developments, including how new innovative approaches are included in the plans for a new cancer centre in Edinburgh.
She has been closely involved in planning the transfer of radiotherapy data to the Scottish Cancer Registry and has a long standing interest in stereotactic radiosurgery and in adaptive radiotherapy.
More information is available at
Leila Shelley is Principal Stereotactic Physicist at the Edinburgh Cancer Centre (UK). She undertook her PhD at the University of Cambridge within the VoxTox Research Group between 2015 – 2019. The focus of her thesis was on accumulating delivered dose using biomechanical modelling to improve prediction of rectal toxicity in prostate radiotherapy.
Prior to commencing her PhD, Leila trained as a Medical Physicist in Edinburgh in 2008, and later worked at the Royal Surrey County Hospital in Guildford, where as well as gaining broad experience across the specialism, she took a keen interest in in-vivo dosimetry using the electronic portal imager. She completed her MSc(MedSci) in Clinical Physics in 2010 from the University of Glasgow, and BSc(hons) in Physics from the University of Edinburgh in 2008.
Michael Trainer is the Head of the Treatment Planning Section at the NHS Lothian Edinburgh Cancer Centre. He is a Consultant Clinical Scientist with expertise in radiotherapy planning for all anatomical sites, including IMRT and SABR for lung cancer. He has responsibility for the introduction of new treatment planning techniques into routine clinical practice. He has detailed knowledge of current 4D imaging techniques and their strengths and weaknesses and advises on adaptation of radiotherapy plans due to changes in patient anatomy.
He is currently in the final stages of the Higher Specialist Scientist Training (HSST) programme, a five-year workplace-based training programme that provides opportunities for clinical scientists to train to consultant clinical scientist level. The research topic being investigated as part of this training programme is on the intra-fractional motion of the prostate during SBRT using an EM Transmitter. Preliminary data from this work was accepted for presentation at ASTRO 2020.
Joanne Mitchell is a Lead Research and Development Radiographer at the Edinburgh Cancer Centre. Her main area of interest is on improving radiotherapy through imaging, particularly magnetic resonance imaging (MRI).
She is a founding member of the Radiotherapy Research Group in Edinburgh and actively involved in radiographer training and research locally and nationally. She is an active member of the UKIO steering committee and has recently been accepted by the University of Edinburgh to study for a PhD in adaptive radiotherapy.